Clariant is launching high-performing pharmaceutical ingredients to support the evolution of safe and effective medicines
NUBEQA is currently indicated for the treatment of adult patients with mHSPC in combination with docetaxel and for non-metastatic castration-resistant prostate cancer (nmCRPC)
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
This office will be the central hub for all operations related to companies ethical pharmaceutical business
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
First-in-human Phase-1 study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SUVN-I6107 in healthy subjects
The low-profile, 2” Disc Top Lite closure offers lighter weight combined with premium customization options
Subscribe To Our Newsletter & Stay Updated
